FCM
ITCI

Frontier Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Frontier Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-98,759
Closed -$1.6M – 335
2017
Q1 		$1.6M Sell
98,759
-1,425
-1% -$20.6K 0.01% 284
2016
Q4 		$1.51M Sell
100,184
-6,397
-6% -$90.3K 0.01% 279
2016
Q3 		$1.62M Buy
106,581
+24,582
+30% +$994K 0.01% 285
2016
Q2 		$3.18M Sell
81,999
-111,615
-58% -$4.01M 0.03% 278
2016
Q1 		$5.38M Sell
193,614
-115,080
-37% -$3.84M 0.04% 269
2015
Q4 		$16.6M Buy
+308,694
New +$15.6M 0.14% 206

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return